Showing results (1181-1190 of 1,523) with videos related to
Sort By:
Pageof 153
Journal of Translational Medicine|July 12, 2013
Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapiesXu-chao Zhang, Jingchuan Zhang, Ming Li, et al.European Journal of Cancer (Oxford, England : 1990)|February 11, 2019
A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)Zhen Wang, Cheng Huang, Jin-Ji Yang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2017
A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858RE-E Ke, Qing Zhou, Qiu-Yi Zhang, et al.Frontiers in Immunology|August 1, 2022
Acinar Cell-Derived Extracellular Vesicle MiRNA-183-5p Aggravates Acute Pancreatitis by Promoting M1 Macrophage Polarization Through Downregulation of FoxO1De-Sheng Tang, Feng Cao, Chang-Sheng Yan, et al.Therapeutic Advances in Medical Oncology|February 9, 2024
Plasma ddPCR for the detection of <i>MET</i> amplification in advanced NSCLC patients: a comparative real-world studyJun-Wei Su, Cheng-Di Weng, Xiao-Cheng Lin, et al.Cancer|June 7, 2023
Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancerQing Zhou, Jun Zhao, Jianhua Chang, et al.The Lancet. Oncology|June 9, 2015
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6James C-H Yang, Lecia V Sequist, Sarayut Lucien Geater, et al.Drugs|December 17, 2020
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating MutationsTony S Mok, Ying Cheng, Xiangdong Zhou, et al.The International Journal of Biological Markers|December 23, 2015
Polymorphism of rs9387478 correlates with overall survival in female nonsmoking patients with lung cancerJie-Fei Han, She-Juan An, Wen-Mei Su, et al.JTO Clinical and Research Reports|January 13, 2022
Clinical Characteristics and Outcomes in Advanced <i>KRAS</i>-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005)Jiyun Lee, Aaron C Tan, Siqin Zhou, et al.Pageof 153